Certainly, the elevation of cortical TSPO binding in MDD patients has an effect size comparable to that seen in our previous meta-analysis showing slightly reduced availability of serotonin transporters in MDD (Gryglewski et al., 2014). The gene discussed is TSPO; the disease is major depressive disorder.